Valneva

Valneva Net Debt

The Net Debt of Valneva (VLA.PA) as of Nov 2, 2026 is 72.26 M EUR. In the previous year, Net Debt was 48.04 M EUR — a change of 50.40% (higher).

Net Debt

72.26 MEUR

YoY

50.40%

Last updated:

Net Debt of Valneva is 2025 72.26 M EUR. Net Debt of Valneva was 2024 48.04 M EUR. It decreases by 50.40% higher compared to the previous year.

The Valneva Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2018
-19.49 M EUR
Jan 1, 2019
20.78 M EUR
Jan 1, 2020
-98.94 M EUR
Jan 1, 2021
-231.99 M EUR
Jan 1, 2022
-137.05 M EUR
Jan 1, 2023
82.74 M EUR
Jan 1, 2024
48.04 M EUR
Jan 1, 2025
72.26 M EUR
The Valneva Net Debt history
YEARNet DebtYoY
72.26 MEUR+50.40%
48.04 MEUR-41.93%
82.74 MEUR-160.37%
-137.05 MEUR-40.92%
-231.99 MEUR+134.47%
-98.94 MEUR-576.21%
20.78 MEUR-206.63%
-19.49 MEUR-151.35%
37.95 MEUR-19.65%
47.24 MEUR-21.73%
60.35 MEUR+36.30%
44.28 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Net Debt of Valneva is 72.26 M EUR in 2025.

Net Debt of Valneva changed from 48.04 M EUR to 72.26 M EUR, representing a 50.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Valneva since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Valneva historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valneva

All Key Metrics — Valneva